Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Gastrin-releasing peptide is a transmitter mediating porcine gallbladder contraction. / Schjoldager, Birgit; Poulsen, S.S.; Schmidt, P.; Coy, David H.; Holst, Jens Juul.

    In: American Journal of Physiology (Consolidated), Vol. 260, No. 4 Pt 1, 04.1991, p. G577-85.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Gastrointestinal Motility in Patients with End-Stage Renal Diease on Chronic Hemodialysis. / Broberg, Bo; Madsen, Jan; Fuglsang, Stefan; Holst, Jens; Christensen, Karl; Rydahl, Casper; Idorn, Thomas; Feldt-Rasmussen, Bo; Hornum, Mads.

    In: Nephrology Dialysis Transplantation, Vol. 33, No. Supplement 1, SaO009 , 2018, p. 318.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Published

    Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease. / Idorn, Thomas; Knop, Filip K; Jørgensen, Morten; Holst, Jens Juul; Hornum, Mads; Feldt-Rasmussen, Bo.

    In: Kidney International, Vol. 83, No. 5, 05.2013, p. 915-23.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Gastrointestinal function and metabolic control after construction of an orthotopic ileal neobladder in bladder cancer. / Thorstenson, Andreas; Jacobsson, Hans; Onelöv, Erik; Holst, Jens Juul; Hellström, Per M; Kinn, Anne-Charlotte.

    In: Scandinavian Journal of Urology and Nephrology, Vol. 41, No. 1, 2007, p. 14-9.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. / Näslund, E.; Grybäck, P.; Hellström, P.M.; Jacobsson, H.; Holst, Jens Juul; Theodorsson, E.; Backmann, L.

    In: International Journal of Obesity, No. 21, 1997, p. 387-392.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis. / Broberg, Bo; Madsen, Jan L.; Fuglsang, Stefan; Holst, Jens J.; Christensen, Karl Bang; Rydahl, Casper; Idorn, Thomas; Feldt-Rasmussen, Bo; Hornum, Mads.

    In: Neurogastroenterology and Motility, Vol. 31, No. 4, e13554, 2019.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Gastrointestinal motility, gut hormone secretion, and energy intake after oral loads of free fatty acid or triglyceride in older and middle-aged men. / Madsen, Jan L.; Damgaard, Morten; Fuglsang, Stefan; Dirksen, Carsten; Holst, Jens J; Graff, Jesper.

    In: Appetite, Vol. 132, 2019, p. 18-24.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. / Hannibal, J.; Mikkelsen, J.D.; Clausen, H.; Holst, Jens Juul; Wulff, B.S.; Fahrenkrug, Jan.

    In: Regulatory Peptides, No. 55, 1995, p. 133-148.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Genetic determinants of circulating GIP and GLP-1 concentrations. / Almgren, Peter; Lindqvist, Andreas; Krus, Ulrika; Hakaste, Liisa; Ottosson-Laakso, Emilia; Asplund, Olof; Sonestedt, Emily; Prasad, Rashmi B; Laurila, Esa; Orho-Melander, Marju; Melander, Olle; Tuomi, Tiinamaija; Holst, Jens Juul; Nilsson, Peter M; Wierup, Nils; Groop, Leif; Ahlqvist, Emma.

    In: JCI Insight, Vol. 2, No. 21, e93306, 02.11.2017.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes. / Ketterer, Caroline; Müssig, Karsten; Heni, Martin; Dudziak, Katarzyna; Randrianarisoa, Elko; Wagner, Robert; Machicao, Fausto; Stefan, Norbert; Holst, Jens Juul; Fritsche, Andreas; Häring, Hans-Ulrich; Staiger, Harald.

    In: Metabolism, Vol. 60, No. 9, 2011, p. 1325-1333.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Ghrelin secretion in humans - a role for the vagus nerve? / Veedfald, S; Plamboeck, A; Hartmann, B; Vilsbøll, T; Knop, F K; Deacon, C F; Svendsen, L B; Holst, J J.

    In: Neurogastroenterology and Motility, Vol. 30, No. 6, e13295, 06.2018.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Ghrelin stimulates gastric emptying and hunger in normal-weight humans. / Levin, F; Edholm, T; Schmidt, P T; Grybäck, P; Jacobsson, H; Degerblad, M; Höybye, C; Holst, Jens Juul; Rehfeld, J F; Hellström, P M; Näslund, E.

    In: The Journal of clinical endocrinology and metabolism, Vol. 91, No. 9, 09.2006, p. 3296-302.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Ghrelin stimulates gastric emptying and hunger in normal-weight humans. / Levin, F.; Edholm, T.; Schmidt, P.T.; Gryback, P.; Jacobsson, H.; Degerblad, M.; Hoybye, C.; Holst, J.J.; Rehfeld, J.F.; Hellstrom, P.M.; Naslund, E.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 91, No. 9, 2006, p. 3296-3302.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome : a randomised phase 2 trial. / Naimi, Rahim M; Hvistendahl, Mark; Enevoldsen, Lotte H; Madsen, Jan L; Fuglsang, Stefan; Poulsen, Steen Seier; Kissow, Hannelouise; Pedersen, Jens; Nerup, Nikolaj; Ambrus, Rikard; Achiam, Michael P; Svendsen, Lars B; Holst, Jens Juul; Hartmann, Bolette; Hansen, Svend H; Dragsted, Lars Ove; Steensberg, Adam; Mouritzen, Ulrik; Hansen, Mark B; Jeppesen, Palle Bekker.

    In: The Lancet Gastroenterology and Hepatology, Vol. 4, No. 5, 2019, p. 354-363.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Gliclazide directly inhibits arginine-induced glucagon release. / Cejvan, Kenan; Coy, David H; Holst, Jens Juul; Cerasi, Erol; Efendic, Suad.

    In: Diabetes, Vol. 51 Suppl 3, 2002, p. S381-4.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Glucagon Receptor Signaling and Glucagon Resistance. / Janah, Lina; Kjeldsen, Sasha; Galsgaard, Katrine D.; Winther-Sorensen, Marie; Stojanovska, Elena; Pedersen, Jens; Knop, Filip K.; Holst, Jens J.; Albrechtsen, Nicolai J. Wewer.

    In: International Journal of Molecular Sciences, Vol. 20, No. 13, 3314, 2019.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published

    Glucagon Receptor Signaling and Lipid Metabolism. / Galsgaard, Katrine D; Pedersen, Jens; Knop, Filip K; Holst, Jens J; Wewer Albrechtsen, Nicolai J.

    In: Frontiers in Physiology, Vol. 10, 413, 2019.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle : The Liver-α-Cell Axis. / Holst, Jens J; Wewer Albrechtsen, Nicolai J; Pedersen, Jens; Knop, Filip K.

    In: Diabetes, Vol. 66, No. 2, 02.2017, p. 235-240.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Glucagon and glucagon-like peptides 1 and 2. / Holst, Jens Juul.

    In: Results and Problems in Cell Differentiation, Vol. 50, 01.01.2010, p. 121-35.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Glucagon and other proglucagon-derived peptides. / Holst, Jens Juul; Ørskov, Cathrine.

    Gut Peptides: Biochemistry and Physiology. New York : Raven Press, 1994. p. 305-340.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  21. Published

    Glucagon antagonism as a potential therapeutic target in type 2 diabetes. / Bagger, J I; Knop, F K; Holst, Jens Juul; Vilsbøll, T.

    In: Diabetes, Obesity and Metabolism, Vol. 13, No. 11, 11.2011, p. 965-971.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Glucagon elimination is increased in patients with type 2 diabetes. / Lund, A. B.; Grøndahl, M. F.; Bagger, J. I.; Holst, J. J.; Christensen, M.; Vilsboll, T.; Knop, F. K.

    In: Diabetologia, Vol. 60, 2017, p. S240-S240.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. / Almdal, Thomas Peter; Holst, Jens Juul; Vilstrup, H.

    In: Diabetes, No. 41, 1992, p. 12-16.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Glucagon like-peptide 1 receptor and the liver. / Pedersen, Jens; Holst, Jens Juul.

    In: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, No. 9, 2011, p. 1243-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals. / Bagger, Jonatan I; Knop, Filip K; Lund, Asger; Holst, Jens Juul; Vilsbøll, Tina.

    In: Diabetologia, Vol. 57, No. 8, 31.05.2014, p. 1270-25.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis. / Knop, F K; Vilsbøll, T; Larsen, Steen; Madsbad, S; Holst, Jens Juul; Krarup, Troels Magelund.

    In: Regulatory Peptides, Vol. 164, No. 2-3, 24.09.2010, p. 144-50.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Glucagon-Like Peptide-1 (GLP-1) Response to Oral Glucose is Reduced in Pre-diabetes, Screen-detected Type 2 Diabetes and Obesity, and Influenced by Sex : The ADDITION-PRO Study. / Færch, Kristine; Torekov, Signe S; Vistisen, Dorte; Johansen, Nanna B; Witte, Daniel R; Jonsson, Anna; Pedersen, Oluf; Hansen, Torben; Lauritzen, Torsten; Sandbæk, Annelli; Holst, Jens Juul; Jørgensen, Marit E.

    In: Diabetes, Vol. 64, 07.2015, p. 2513-25.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans. / Halim, Md. Abdul; Degerblad, Marie; Sundbom, Magnus; Karlbom, Urban; Holst, Jens Juul; Webb, Dominic-Luc; Hellstrom, Per M.

    In: Journal of Clinical Endocrinology & Metabolism, Vol. 103, No. 2, 2018, p. 575-585.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Glucagon-like Peptide-1 and the Central/Peripheral Nervous System : Crosstalk in Diabetes. / Muscogiuri, Giovanna; DeFronzo, Ralph A; Gastaldelli, Amalia; Holst, Jens J.

    In: Trends in Endocrinology and Metabolism, Vol. 28, No. 2, 02.2017, p. 88-103.

    Research output: Contribution to journalReviewResearchpeer-review

  30. Published

    Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using a-glucosidase inhibition (acarbose). / Qualmann, C.; Nauck, M.A.; Holst, Jens Juul; Ørskov, Cathrine; Creutzfeldt, W.

    In: Scandinavian Journal of Gastroenterology, No. 30, 1995, p. 892-896.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. / Gromada, J; Bokvist, K; Ding, W G; Holst, J J; Nielsen, Jens Høiriis; Rorsman, P.

    In: Diabetes, Vol. 47, No. 1, 1998, p. 57-65.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. / Hagemann, Dirk; Holst, Jens Juul; Gethmann, Arnica; Banasch, Matthias; Schmidt, Wolfgang E; Meier, Juris J.

    In: Regulatory Peptides, Vol. 143, No. 1-3, 04.10.2007, p. 64-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. / Hagemann, D.; Holst, J.J.; Gethmann, A.; Banasch, M.; Schmidt, W.E.; Meier, J.J.

    In: Regulatory Peptides, Vol. 143, No. 1-3, 2007, p. 64-68.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Glucagon-like peptide 1 (GLP-1)(7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). / Qualmann, C.; Nauck, M.A.; Holst, Jens Juul; Ørskov, C.; Creutzfeldt, W.

    In: Scandinavian Journal of Gastroenterology, No. 30, 1995, p. 892-896.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Glucagon-like peptide 1 - a new hormone which may change the treatment of non-insulin dependent diabetes mellitus. / Holst, Jens Juul; Ørskov, Cathrine.

    In: MedView, No. 6, 1992, p. 259-263.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. / Meier, J J; Gethmann, A; Götze, O; Gallwitz, B; Holst, Jens Juul; Schmidt, W E; Nauck, M A.

    In: Diabetologia, Vol. 49, No. 3, 03.2006, p. 452-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. / Meier, J.J.; Gethmann, A.; Gotze, O.; Gallwitz, B.; Holst, J.J.; Schmidt, W.E.; Nauck, M.A.

    In: Diabetologia, Vol. 49, No. 3, 2006, p. 452-458.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. / Asmar, Meena; Holst, Jens Juul.

    In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 17, No. 1, 01.02.2010, p. 57-62.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Current Opinion in Pharmacology, Vol. 4, No. 6, 2004, p. 589-96.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion. / Porksen, N.; Grøfte, T.; Nyholm, Birgit; Holst, J.J.; Pincus, S.M.; Veldhuis, J.D.; Schmitz, O.; Butler, P.C.

    In: Diabetes, No. 47, 1998, p. 45-49.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. / Ritzel, R.; Schulte, M.; Porksen, N.; Holst, J.J.

    In: Diabetes, No. 50, 2001, p. 776-784.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. / Nauck, M A; Niedereichholz, U; Ettler, R; Holst, J J; Orskov, C; Ritzel, R; Schmiegel, W H.

    In: American Journal of Physiology (Consolidated), Vol. 273, No. 5 Pt 1, 11.1997, p. E981-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. / Flint, A.; Raben, Anne; Astrup, Arne; Holst, Jens Juul.

    In: Journal of Clinical Investigation, Vol. 101, No. 3, 1998, p. 515-520.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    Glucagon-like peptide 1: on its way to clinical application. / Göke, B.; Göke, R.; Holst, Jens Juul; Ørskov, Cathrine.

    In: Digestion, No. 54, 1994, p. 339-340.

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Glucagon-like peptide 1: physiology and therapeutic potential. / Holst, Jens Juul.

    In: Endocrinology and Diabetes, No. 12, 2005, p. 56-62.

    Research output: Contribution to journalJournal articleResearch

  46. Published

    Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. / Thulesen, J; Hartmann, B; Hare, K J; Kissow, H; Ørskov, C; Holst, Jens Juul; Poulsen, S S.

    In: Gut, Vol. 53, No. 8, 08.2004, p. 1145-1150.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Glucagon-like peptide 2 (Glp-2) stimulates intestinal function during weaning. / Thymann, Thomas; Huërou-Luron, I. Le; Petersen, Y.M.; Hedemann, Mette Skou; Elnif, Jan; Jensen, B.B.; Hartmann, Bolette; Holst, Jens Juul; Sangild, Per Torp.

    44th annual meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, 2011: programme and abstract booklet. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), 2011. p. 202.

    Research output: Chapter in Book/Report/Conference proceedingConference abstract in proceedingsResearch

  48. Published

    Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. / Burrin, Douglas G; Stoll, Barbara; Guan, Xinfu; Cui, Liwei; Chang, Xiaoyan; Holst, Jens Juul.

    In: Endocrinology, Vol. 146, No. 1, 01.2005, p. 22-32.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Glucagon-like peptide 2 has limited efficacy to increase nutrient absorption in fetal and preterm pigs. / Sangild, Per Torp; Malo, Christiane; Schmidt, Mette; Petersen, Yvette M.; Elnif, Jan; Holst, Jens Juul; Bunddington, Randal K.

    In: American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, Vol. 293, No. 6, 2007, p. R2179-R2184.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. / Jeppesen, P B; Hartmann, B; Thulesen, J; Graff, J; Lohmann, J; Hansen, B S; Tofteng, F; Poulsen, Steen Seier; Madsen, J L; Holst, J J; Mortensen, P B.

    In: Gastroenterology, Vol. 120, No. 4, 03.2001, p. 806-815.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Glucagon-like peptide 2 inhibits ghrelin secretion in humans. / Banasch, Matthias; Bulut, Kerem; Hagemann, Dirk; Schrader, Henning; Holst, Jens Juul; Schmidt, Wolfgang E; Meier, Juris J.

    In: Regulatory Peptides, Vol. 137, No. 3, 10.12.2006, p. 173-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. / Meier, J.J.; Nauck, M.A.; Pott, A.; Heinze, K.; Goetze, O.; Bulut, K.; Schmidt, W.E.; Gallwitz, B.; Holst, J.J.

    In: Today in Medicine. Gastroenterology, Vol. 130, No. 1, 2006, p. 44-54.

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. Published

    Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. / Meier, Juris J; Nauck, Michael A; Pott, Andrea; Heinze, Kai; Goetze, Oliver; Bulut, Kerem; Schmidt, Wolfgang E; Gallwitz, Baptist; Holst, Jens Juul.

    In: Gastroenterology, Vol. 130, No. 1, 01.2006, p. 44-54.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    Glucagon-like peptide 2 stimulates intestinal growth by decreasing proteolysis and apoptosis in parenterally fed premature piglets. / Burrin, D. G.; Stoll, B.; Jiang, R.; Petersen, Y.; Elnif, J.; Buddington, R. K.; Schmidt, M.; Holst, Jens Juul; Hartmann, B.; Sangild, P. T.

    Ikke angivet. ed. / J. E. Lindberg; Ogle; B. CABI Publishing, 2001. p. 40-42.

    Research output: Chapter in Book/Report/Conference proceedingArticle in proceedingsResearch

  55. Published

    Glucagon-like peptide 2 stimulates small-intestine growth and maturation in the pig fetus and neonate. / Petersen, Y. M.; Burrin, D. G.; Schmidt, M.; Elnif, J.; Hartmann, B.; Holst, Jens Juul; Sangild, P. T.

    Ikke angivet. ed. / J. E. Lindberg; Ogle; B. CABI Publishing, 2001. p. 23-25.

    Research output: Chapter in Book/Report/Conference proceedingArticle in proceedingsResearch

  56. Published

    Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning. / Thymann, Thomas; Le Huërou-Luron, I; Petersen, Y M; Hedemann, Mette Skou; Elinf, J; Jensen, B B; Holst, Jens Juul; Hartmann, Bolette; Sangild, Per Torp.

    In: Journal of Animal Science, Vol. 92, No. 5, 2014, p. 2070-2079.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. / Orskov, C; Poulsen, Steen Seier; Møller, M; Holst, J J.

    In: Diabetes, Vol. 45, No. 6, 06.1996, p. 832-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes : a review of clinical trials. / Madsbad, Sten; Krarup, Thure; Deacon, Carolyn F; Holst, Jens Juul.

    In: Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 11, No. 4, 07.2008, p. 491-9.

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. Published

    Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials. / Madsbad, Sten; Krarup, Thure; Deacon, Carolyn F; Holst, Jens Juul; Madsbad, Sten; Krarup, Thure; Deacon, Carolyn F; Holst, Jens J.

    In: Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 11, No. 4, 2008, p. 491-9.

    Research output: Contribution to journalJournal articleResearchpeer-review

  60. Published

    Glucagon-like peptide- 1 secretion is influenced by perfusate glucose concentration and a feedback mechanism involving somatostatin in isolated perfused porcine ileum. / Hansen, L.; Hartmann, B.; Mineo, H.; Holst, J.J.

    In: Regul. Pept., No. 118, 2004, p. 11-18.

    Research output: Contribution to journalJournal articleResearchpeer-review

  61. Published

    Glucagon-like peptide-1 : from extract to agent. The Claude Bernard Lecture, 2005. / Holst, Jens Juul.

    In: Diabetologia, Vol. 49, No. 2, 02.2006, p. 253-60.

    Research output: Contribution to journalJournal articleCommunication

  62. Published

    Glucagon-like peptide-1 : a basis for new approaches to the management of diabetes. / Deacon, C F; Holst, Jens Juul; Carr, R D.

    In: Drugs of Today, Vol. 35, No. 3, 03.1999, p. 159-70.

    Research output: Contribution to journalJournal articleResearchpeer-review

  63. Published

    Glucagon-like peptide-1 (GLP-1) : effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. / Skov, Jeppe; Dejgaard, Anders; Frøkiær, Jørgen; Holst, Jens Juul; Jonassen, Thomas; Rittig, Søren; Christiansen, Jens Sandahl.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 98, No. 4, 04.2013, p. E664-71.

    Research output: Contribution to journalJournal articleResearchpeer-review

  64. Published

    Glucagon-like peptide-1 (GLP-1) - A newly discovered Gl Hormone. Review. / Holst, Jens Juul.

    In: Today in Medicine. Gastroenterology, No. 107, 1994, p. 1848-1855.

    Research output: Contribution to journalJournal articleResearchpeer-review

  65. Published

    Glucagon-like peptide-1 (GLP-1) 7-36 amide and peptide YY from L-cell in the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. / Wettergren, André; Petersen, H.; Ørskov, Cathrine; Christiansen, J.; Sheikh, S.; Holst, Jens Juul.

    In: Scandinavian Journal of Gastroenterology, No. 29, 1994, p. 501-505.

    Research output: Contribution to journalJournal articleResearchpeer-review

  66. Published

    Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes. / Nauck, M.A.; Holst, Jens Juul; Willms, B.; Schmiegel, W.

    In: Exp. Clin. Endocrinol. Diabetes, No. 105, 1997, p. 187-195.

    Research output: Contribution to journalJournal articleResearchpeer-review

  67. Published

    Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. / Gejl, Michael; Lerche, Susanne; Egefjord, Lærke; Brock, Birgitte; Møller, Niels; Vang, Kim; Rodell, Anders; Bibby, Bo Martin; Holst, Jens Juul; Rungby, Jørgen; Gjedde, Albert.

    In: Frontiers in Neuroenergetics, Vol. 5, 2, 2013, p. 1-9.

    Research output: Contribution to journalJournal articleResearchpeer-review

  68. Published

    Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. / Kissow, Hannelouise; Hartmann, Bolette; Holst, Jens Juul; Viby, Niels-Erik; Hansen, Lærke Schmidt; Rosenkilde, Mette Marie; Hare, Kristine Juul; Poulsen, Steen Seier.

    In: Regulatory Peptides, Vol. 179, No. 1-3, 10.11.2012, p. 91-100.

    Research output: Contribution to journalJournal articleResearchpeer-review

  69. Published

    Glucagon-like peptide-1 (GLP-1), Entleerung des Magenersatzes und das Dumpingsyndrom nach Gastrektomie. / Miholic, J.; Ørskov, Cathrine; Holst, Jens Juul; Meyer, H.-J.; Pichlmayr, R.

    In: Langerbecks Archiv für Chirurgie. (108. Kongress der Deutsch.Gesellsch.Chirurgie, No. Suppl.1991, 1991, p. 430-432.

    Research output: Contribution to journalJournal articleResearchpeer-review

  70. Published

    Glucagon-like peptide-1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential. / Holst, J.J.

    In: Trends in Endocrinology and Metabolism, No. 10, 1999, p. 229-235.

    Research output: Contribution to journalJournal articleResearchpeer-review

  71. Published

    Glucagon-like peptide-1 (GLP-17-36amide) reduces hepatic glucose production indirectly through changes in insulin and glucagon secretion. / Larsson, H.; Holst, Jens Juul; Ahrén, Bo.

    In: Acta Phys. Scand., No. 160, 1997, p. 413-422.

    Research output: Contribution to journalJournal articleResearchpeer-review

  72. Published

    Glucagon-like peptide-1 - a new hormone and a new drug. / Holst, J.J.

    In: Ugeskrift for læger, No. 160, 1998, p. 2371-2377.

    Research output: Contribution to journalJournal articleResearchpeer-review

  73. Published

    Glucagon-like peptide-1 - et nyt hormon med mulig anvendelse i diabetesbehandlingen. / Holst, Jens Juul.

    In: Tidsskrift for Diabetesbehandling, No. 3, 1993, p. 33-39.

    Research output: Contribution to journalJournal articleResearch

  74. Published

    Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. / Wettergren, A; Petersen, H; Orskov, C; Christiansen, J; Sheikh, S P; Holst, J J.

    In: Scandinavian Journal of Gastroenterology, Vol. 29, No. 6, 06.1994, p. 501-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  75. Published

    Glucagon-like peptide-1 7-36amide and peptide YY have additive inhibitory effects on gastric acid secretion in man. / Wettergren, A.; Maina, P.; Boesby, S.; Holst, Jens Juul.

    In: Scandinavian Journal of Gastroenterology, No. 32, 1997, p. 552-555.

    Research output: Contribution to journalJournal articleResearchpeer-review

  76. Published

    Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors. / Ronn, Jonas; Jensen, Elisa P; Wewer Albrechtsen, Nicolai J; Holst, Jens Juul; Sorensen, Charlotte M.

    In: Physiological Reports, Vol. 5, No. 23, e13503, 12.2017.

    Research output: Contribution to journalJournal articleResearchpeer-review

  77. Published

    Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis. / Kissow, Hannelouise; Hartmann, Bolette; Holst, Jens Juul; Poulsen, Steen Seier.

    In: Gut, 20.10.2012.

    Research output: Contribution to journalJournal articleResearchpeer-review

  78. Published

    Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia. / Gejl, Michael; Egefjord, Lærke; Lerche, Susanne; Vang, Kim; Bibby, Bo Martin; Holst, Jens Juul; Mengel, Annette; Møller, Niels; Rungby, Jørgen; Brock, Birgitte; Gjedde, Albert.

    In: Journal of Cerebral Blood Flow and Metabolism, Vol. 32, No. 12, 12.2012, p. 2146-2152.

    Research output: Contribution to journalJournal articleResearchpeer-review

  79. Published

    Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy. / Asmar, Ali; Simonsen, Lene; Asmar, Meena; Madsbad, Sten; Holst, Jens J; Frandsen, Erik; Moro, Cedric; Sorensen, Charlotte M; Jonassen, Thomas; Bulow, Jens.

    In: American Journal of Physiology: Endocrinology and Metabolism, Vol. 310, No. 9, 05.2016, p. E744-E753.

    Research output: Contribution to journalJournal articleResearchpeer-review

  80. Published

    Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men. / Asmar, Ali; Asmar, Meena; Simonsen, Lene; Madsbad, Sten; Holst, Jens J; Hartmann, Bolette; Sorensen, Charlotte M; Bülow, Jens.

    In: Physiological Reports, Vol. 5, No. 3, e13073, 02.2017.

    Research output: Contribution to journalJournal articleResearchpeer-review

  81. Published

    Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans. / Lerche, Susanne; Brock, Birgitte; Rungby, Jørgen; Bøtker, Hans E; Møller, Niels; Rodell, Anders; Bibby, Bo Martin; Holst, Jens J; Schmitz, Ole; Gjedde, Albert.

    In: Diabetes, Vol. 57, No. 2, 2008, p. 325-31.

    Research output: Contribution to journalJournal articleResearchpeer-review

  82. Published

    Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. / Wettergren, A.; Wojdemann, M.; Holst, J.J.

    In: Am. J. Physiol., No. 275, 1998, p. G984-G992.

    Research output: Contribution to journalJournal articleResearchpeer-review

  83. Published

    Glucagon-like peptide-1 is a marker of systemic inflammation in patients treated with high-dose chemotherapy and autologous stem cell transplantation. / Ebbesen, M S; Kissow, H; Hartmann, B; Grell, K; Gørløv, J S; Kielsen, K; Holst, J J; Müller, K.

    In: Biology of Blood and Marrow Transplantation, Vol. 25, No. 6, 2019, p. 1085-1091.

    Research output: Contribution to journalJournal articleResearchpeer-review

  84. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. / Holst, Jens Juul; Deacon, C F.

    In: Diabetologia, Vol. 48, No. 4, 04.2005, p. 612-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  85. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  86. Published

    Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans. / Flint, A.; Raben, A.; Holst, Jens Juul; Astrup, A.

    International journal of obesity. 21. ed. European Association for the Study of Obesity, 1997. p. 16.

    Research output: Chapter in Book/Report/Conference proceedingArticle in proceedingsResearch

  87. Published
  88. Published

    Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: Dig. Dis. Sci., No. 43, 1998, p. 2284-2290.

    Research output: Contribution to journalJournal articleResearchpeer-review

  89. Published

    Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. / Hansen, Lene; Hartmann, Bolette; Mineo, Hitoshi; Holst, Jens Juul.

    In: Regulatory Peptides, Vol. 118, No. 1-2, 15.04.2004, p. 11-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  90. Published

    Glucagon-like peptide-1 slows solid gastric emptying and inhibits insulin, glucagon and peptide YY release in humans. / Näslund, E.; Bogefors, J.; Skogar, S.; Grybäck, P.; Jacobsen, H.L.; Holst, J.J.; Helström, P.M.

    In: Am. J. Physiol., No. 277, 1999, p. 910-916.

    Research output: Contribution to journalJournal articleResearchpeer-review

  91. Published

    Glucagon-like peptide-1 suppresses energy expenditure in obese humans. / Flint, A.; Raben, A.; Holst, Jens Juul; Astrup, A.

    International journal of obesity. ed. / J.-P. Després; I. Macdonald. 23. ed. European Association for the Study of Obesity, 1999. p. S35.

    Research output: Chapter in Book/Report/Conference proceedingArticle in proceedingsResearch

  92. Published

    Glucagon-like peptide-1(7-36)amide is transformed to glucagon-like peptide-1 (9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the intestinal L-cells. / Hansen, L.; Deacon, C.F.; Ørskov, C.; Holst, J.J.

    In: Endokrinologiya, No. 140, 1999, p. 5356-5363.

    Research output: Contribution to journalJournal articleResearchpeer-review

  93. Published

    Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential. / Holst, J.J.

    In: Current Medicinal Chemistry, No. 6, 1999, p. 1005-1017.

    Research output: Contribution to journalJournal articleResearchpeer-review

  94. Published

    Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. / de, Heer J.; Rasmussen, C.; Coy, D.H.; Holst, Jens Juul.

    In: Diabetologia, Vol. 51, No. 12, 2008, p. 2263-2270.

    Research output: Contribution to journalJournal articleResearchpeer-review

  95. Published

    Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. / de Heer, J; Rasmussen, C; Coy, D H; Holst, Jens Juul.

    In: Diabetologia, Vol. 51, No. 12, 12.2008, p. 2263-70.

    Research output: Contribution to journalJournal articleResearchpeer-review

  96. Published

    Glucagon-like peptide-1, glucose homeostasis and diabetes. / Holst, Jens Juul; Deacon, Carolyn F; Vilsbøll, Tina; Krarup, Thure; Madsbad, Sten.

    In: Trends in Molecular Medicine, Vol. 14, No. 4, 2008, p. 161-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  97. Published

    Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. / Hansen, L; Deacon, C F; Orskov, C; Holst, J J.

    In: Molecular Endocrinology, Vol. 140, No. 11, 11.1999, p. 5356-63.

    Research output: Contribution to journalJournal articleResearchpeer-review

  98. Published

    Glucagon-like peptide-1: A basis for new approaches to the management of Diabetes. / Deacon, C.F.; Holst, J.J.; Carr, R.D.

    In: Drugs of Today, No. 35, 1999, p. 159-170.

    Research output: Contribution to journalJournal articleResearchpeer-review

  99. Published

    Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005. / Holst, J.J.

    In: Diabetologia, Vol. 49, No. 2, 2006, p. 253-260.

    Research output: Contribution to journalJournal articleResearchpeer-review

  100. Published

    Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. / Skov, Jeppe; Holst, Jens Juul; Gøtze, Jens Peter; Frøkiær, Jørgen; Christiansen, Jens Sandahl.

    In: Endocrine Connections, Vol. 3, No. 1, 2014, p. 11-6.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 12 3 4 5 6 7 8 9 ...15 Next

ID: 4207